NCT03029169View on ClinicalTrials.gov

Propafenone Versus Amiodarone in Septic Shock

PHASE4CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

October 23, 2017

Primary Completion Date

July 4, 2022

Study Completion Date

August 1, 2022

Conditions
Supraventricular ArrhythmiaSeptic Shock
Interventions
DRUG

Propafenone i.v.

Treatment

DRUG

Amiodarone i.v.

Treatment

Trial Locations (2)

100 34

Dept. Anaesthesia and Intensive Care, 3rd Medical Faculty, Charles University, Prague

128 08

Dept of Anaesthesia and Intensive Care, General University Hospital, 1st Medical Faculty, Charles University, Prague

All Listed Sponsors
lead

Charles University, Czech Republic

OTHER

NCT03029169 - Propafenone Versus Amiodarone in Septic Shock | Biotech Hunter | Biotech Hunter